Search results
20 hours ago · Baxter is considering the sale of its kidney care business to private equity firm Carlyle Group for more than $4 billion, The Wall Street Journal reported on Friday. Exclusive negotiations about a potential sale started in late June, the Journal reported, citing unnamed sources. A deal could be announced “in the coming weeks,” although the ...
3 days ago · Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter ...
20 hours ago · Shares of Baxter International BAX have gained 2.8% since Jun 26, after the company announced the recall of its Life2000 Ventilation System. Though the share price had declined following the news ...
Jun 28, 2024 · Baxter's clinically-proven portfolio of surgical products allow surgery teams freedom to innovate and think creatively without restraint in the operating room.
3 days ago · Stock analysis for Baxter International Inc (BAX:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
- 60K
20 hours ago · Carlyle is negotiating to acquire Baxter International's kidney-care spinoff, Vantive, in a $4 billion deal, including debt. The deal reflects a significant move in private-equity dealmaking and ...
People also ask
What is the Baxter?
Who uses Baxter International Inc (Bax) products?
What makes Baxter unique?
Will Carlyle buy Baxter & Vantive?
3 days ago · Deal would value the Baxter spinoff at more than $4 billion. The deal would be Carlyle’s latest at a time when private-equity dealmaking is slowly coming back to life. Photo: issei kato/Reuters ...